J&J to Pay $25M Settlement Over Recalled Infant Tylenol, Children’s Motrin, Other Drugs

Johnson & Johnson’s McNeil-PPC Inc. subsidiary has agreed to plead guilty to charges that it knowingly allowed tens of millions of bottles of children’s drugs to be shipped out, even though they were contaminated with metal particles.

According to a Justice Department and FDA press release issued on March 10, the drug maker will pay $25 million in fines and forfeitures as part of a settlement that results charges that McNeil violated the federal Food, Drug and Cosmetic Act (FDCA) when it shipped out millions of bottles of Infants’ Tylenol, Children’s Tylenol, Children’s Motrin and other over-the-counter drugs despite knowing that they were contaminated with dark flecks which turned out to be metal particles.

“Drug quality – and especially with the medicines we give our children – is of paramount concern to the FDA. The FDA expects manufacturers to have systems in place that will quickly discover and correct problems with medical products before they enter the U.S. marketplace,” FDA Commissioner Dr. Margaret Hamburg said in the press release. “Today’s guilty plea holds accountable those corporations who risk jeopardizing the public health by not adhering to the high standards set for drug manufacturers.”

Tylenol Autism Lawsuit

Does your child have Austism from Tylenol Exposure?

Side effects of Tylenol may cause autism and ADHD among children exposed during pregnancy. Find out if your family may be eligible for a Tylenol autism or ADHD settlement.

Learn More About this Lawsuit See If You Qualify For Compensation

The initial McNeil Healthcare children’s medication recall on April 30, 2010, affected 40 different liquid medication products, including Tylenol, Benadryl, Motrin and Zyrtec. McNeil is a subsidiary of Johnson & Johnson.

The recall affected 136 million bottles of children’s medications, and resulted in the shutdown of the company’s Ft. Washington, Pennsylvania, plant, and the suspension of the production of all of McNeil’s children medications.

Following that recall, the FDA received nearly 800 complaints of problems associated with the drugs, including at least seven reports of deaths among children using the medications.

Court documents have revealed that McNeil began receiving complaints as early as May 1, 2009, about a year before it announced the recall. The first consumer complaint warned that there were black specks in the liquid of Infant’s Tylenol, but the company failed to address the complaint in conformance with current Good Manufacturing Practices. The material was later identified as nickel/chromium-rich inclusions.

There were several instances where the company found metal particles in bottles of Infant Tylenol at the Fort Washington plant, but the company repeatedly failed to address them properly. The company did not recall the drugs until after FDA inspections revealed the problems and that the company did not have a Corrective Action Preventative Action (CAPA) plan to deal with the problem.

The company was hit by a consent decree filed by the U.S. Department of Justice Office of Consumer Litigation, and the U.S. Attorney’s Office for the Eastern District of Pennsylvania.

The decree shut down the Fort Washington plant and required the company to destroy the affected drugs, and to hire independent experts on current Good Manufacturing Procedures to oversee rehabilitation of the Fort Washington facility, as well as plants in Lancaster, Pennsylvania and Las Piedras, Puerto Rico. The company had to pay all of the FDA’s employee, laboratory, and mileage expenses as part of the deal.

The company faced fines of up to $10 million a year if it failed to comply with the consent decree and remains under a permanent injunction to make necessary changes before it can reopen the Fort Washington facility.

This week’s agreement adds a $20 million criminal fine and $5 million in profit forfeitures to the penalties already faced by the company.

“The law requires that drugs be produced under the most rigorous of quality standards, When companies fail to exercise the vigilance that the law demands, they will be held accountable,” First Assistant U.S. Attorney Louis D. Lappen said in the press release. “Drug companies should be aware that failing to adhere to good manufacturing practices subjects them to penalties and prosecution.”


  • DianaJanuary 16, 2020 at 6:09 pm

    My son has used Tylenol all of his life and in the hospital he has lots of illnesses can u help me. Thank you

  • BrendaJanuary 15, 2020 at 7:20 pm

    We used Tylenol for our granddaughter during this time as an infant & toddler.

  • HeatherMarch 18, 2017 at 1:59 pm

    My daughter has used the medicine. How do I report this?

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Management of Ozempic Lawsuit Pretrial Proceedings To Be Reassigned Following Death of MDL Judge
Management of Ozempic Lawsuit Pretrial Proceedings To Be Reassigned Following Death of MDL Judge (Posted today)

The judge overseeing Ozempic lawsuits consolidated in federal court has died, requiring a new judge to be assigned to oversee coordinated pretrial proceedings over claims the diabetes drug and similar medications caused stomach paralysis and other intestinal complications.

Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination
Baby Food Injury Lawyers Appointed To Leadership Roles in Autism, ADHD Lawsuits Over Heavy Metal Contamination (Posted 2 days ago)

A group of 19 plaintiffs' lawyers have been appointed to serve in various leadership position during the consolidated pretrial proceedings for all baby food injury lawsuits, taking actions that benefit all families pursuing claims for children diagnosed with autism, ADHD or other developmental problems from toxic heavy metals found in many popular products sold in recent years.